Clinical trial
Genistein and Interleukin-2 in Treating Patients With Metastatic Melanoma or…
NCT00276835 · Northwestern University, Other · Completed
Key facts
| NCT number | NCT00276835 |
|---|---|
| Title | Genistein and Interleukin-2 in Treating Patients With Metastatic Melanoma or Kidney Cancer |
| Official title | A Pilot Study of the Effect of Genistein in Combination With High-Dose Interleukin-2 on Cell Expansion and Gene Expression in Patients With Metastatic Melanoma or Renal Cell Carcinoma |
| Lead sponsor | Northwestern University, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Early Phase 1 |
| Study type | Interventional |
| Conditions | Kidney Cancer, Melanoma (Skin) |
| Intervention type | Biological, Dietary Supplement |
| Interventions | High-dose interleukin-2, genistein |
| Enrollment | 15 |
| Start date | Nov 1, 2005 |
| Primary completion | Jul 1, 2007 |
| Completion | Jan 1, 2014 |
| First posted | Jan 13, 2006 |
| Last update posted | Apr 10, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: